COZZA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.103
AS - Asia 2.788
EU - Europa 2.565
AF - Africa 673
SA - Sud America 632
OC - Oceania 63
Continente sconosciuto - Info sul continente non disponibili 34
Totale 15.858
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.748
SG - Singapore 780
CN - Cina 765
IT - Italia 626
DE - Germania 426
BR - Brasile 422
HK - Hong Kong 341
FI - Finlandia 325
VN - Vietnam 147
SE - Svezia 127
PL - Polonia 123
GB - Regno Unito 96
RU - Federazione Russa 96
NL - Olanda 80
UA - Ucraina 73
FR - Francia 69
IN - India 60
KR - Corea 49
AT - Austria 37
MX - Messico 36
TR - Turchia 35
EC - Ecuador 34
CA - Canada 33
IQ - Iraq 33
IE - Irlanda 32
CI - Costa d'Avorio 31
VE - Venezuela 31
AL - Albania 30
ID - Indonesia 30
JP - Giappone 30
ZA - Sudafrica 30
ES - Italia 29
GE - Georgia 28
KG - Kirghizistan 28
HN - Honduras 27
MD - Moldavia 26
BE - Belgio 25
BY - Bielorussia 24
AO - Angola 23
AR - Argentina 23
CO - Colombia 23
EE - Estonia 23
TW - Taiwan 23
CZ - Repubblica Ceca 22
GT - Guatemala 22
IR - Iran 22
PH - Filippine 22
PY - Paraguay 22
TZ - Tanzania 22
AE - Emirati Arabi Uniti 21
AF - Afghanistan, Repubblica islamica di 21
BJ - Benin 21
CW - ???statistics.table.value.countryCode.CW??? 21
HU - Ungheria 21
NP - Nepal 21
AM - Armenia 20
MA - Marocco 20
ML - Mali 20
MU - Mauritius 20
PK - Pakistan 20
PT - Portogallo 20
TN - Tunisia 20
BD - Bangladesh 19
GA - Gabon 19
JM - Giamaica 19
PE - Perù 19
SA - Arabia Saudita 19
UZ - Uzbekistan 19
BB - Barbados 18
CL - Cile 18
GM - Gambi 18
IS - Islanda 18
KZ - Kazakistan 18
LA - Repubblica Popolare Democratica del Laos 18
ME - Montenegro 18
PA - Panama 18
RO - Romania 18
UG - Uganda 18
ZM - Zambia 18
EG - Egitto 17
GN - Guinea 17
IL - Israele 17
LY - Libia 17
NC - Nuova Caledonia 17
TJ - Tagikistan 17
YT - Mayotte 17
BZ - Belize 16
CM - Camerun 16
CV - Capo Verde 16
JO - Giordania 16
LB - Libano 16
MK - Macedonia 16
MW - Malawi 16
RE - Reunion 16
ZW - Zimbabwe 16
BA - Bosnia-Erzegovina 15
BG - Bulgaria 15
CG - Congo 15
KE - Kenya 15
LV - Lettonia 15
Totale 15.125
Salva come PNG Salva come JPEG
Città #
Fairfield 1.288
Woodbridge 849
Ashburn 778
Houston 726
Ann Arbor 685
Chandler 524
Singapore 511
Cambridge 490
Seattle 471
Wilmington 462
Hong Kong 327
Munich 255
Jacksonville 252
Beijing 232
Padova 190
Helsinki 168
Boardman 159
Santa Clara 157
Princeton 138
San Diego 124
Des Moines 110
Bytom 91
Medford 79
Los Angeles 71
Nanjing 68
Dong Ket 63
Turku 54
Roxbury 51
Hefei 43
Buffalo 40
Guangzhou 37
Milan 34
New York 34
Seoul 34
São Paulo 33
Ho Chi Minh City 32
Redondo Beach 31
Abidjan 30
Chicago 29
Dublin 29
Shenyang 28
Hebei 27
Jinan 25
Bishkek 23
Vienna 23
Hanoi 22
Tbilisi 22
London 21
Nanchang 20
Bamako 19
Luanda 19
Minsk 19
Nuremberg 19
Libreville 18
Lusaka 18
Tallinn 18
Yerevan 18
Bridgetown 17
Brooklyn 17
Conakry 17
Cotonou 17
Dallas 17
Dar es Salaam 17
Dushanbe 17
Kampala 17
Noumea 17
Panama City 17
Salt Lake City 17
Tokyo 17
Vientiane 17
Amman 16
Chisinau 16
Rome 16
Tashkent 16
Changsha 15
Managua 15
Tianjin 15
Tirana 15
Willemstad 15
Antananarivo 14
Baghdad 14
Harare 14
Kingstown 14
Montevideo 14
Praia 14
Accra 13
Boston 13
Dakar 13
Djibouti 13
Jiaxing 13
Kingston 13
Nairobi 13
Podgorica 13
Tripoli 13
Addis Ababa 12
Baku 12
Brazzaville 12
Castries 12
Chennai 12
Dili 12
Totale 10.771
Salva come PNG Salva come JPEG
Nome #
Insight into the mechanism of ferroptosis inhibition by ferrostatin-1 484
Lipid peroxidation and GPx4: the players of the oxygen paradox 285
"Genuine" Casein Kinase: The False Sister of CK2 That Phosphorylates Secreted Proteins at S-X-E/pS Motifs 263
A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours 256
Stealth iron oxide nanoparticles for organotropic drug targeting 235
Inactivation of the glutathione peroxidase GPx4 by the ferroptosis-inducing molecule RSL3 requires the adaptor protein 14-3-3 epsilon 230
ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors. 229
Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity 214
Lack of glutathione peroxidase-8 in the ER impacts on lipid composition of HeLa cells microsomal membranes 210
Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight. 209
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2 208
Protein disulfide isomerase and glutathione are alternative substrates in the one Cys catalytic cycle of glutathione peroxidase 7 203
A novel glucosyltransferase from Catharanthus roseus cell suspensions 195
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease 195
The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation 194
Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application. 193
Strategie computazionali per lo studio delle interazioni tra macromolecole e per la ricerca di nuovi inibitori di proteine chinasi 186
Benextramine and derivatives as novel human monoamine oxidases inhibitors: an integrated approach 184
A Comparison of Thiol Peroxidase Mechanisms 178
Pyrazoloquinazoline tricyclic system as novel scaffold to design new kinase CK2 inhibitors 175
8-Hydroxynaphthalene-1,4-dione derivative as novel compound for glioma treatment 173
Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases 171
Insight the mechanism of ferroptosis inhibition by ferrostatin-1 171
Glutathione peroxidase 4-catalyzed reduction of lipid hydroperoxides in membranes: The polar head of membrane phospholipids binds the enzyme and addresses the fatty acid hydroperoxide group toward the redox center 169
Understanding mammalian glutathione peroxidase 7 in the light of its homologs 168
The lysine-specific demethylase 1 is a novel substrate of protein kinase CK2 167
Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors 166
Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study 165
Synthesis and properties of a selective inhibitor of homeodomain-interacting protein kinase 2 (HIPK2). 165
Covalently bound DNA on naked iron oxide nanoparticles: Intelligent colloidal nano-vector for cell transfection 163
Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential 161
The acidophilic kinases PLK2 and PLK3: structure, substrate targeting and inhibition 161
Chimeric peptides as modulators of CK2-dependent signaling: Mechanism of action and off-target effects 160
Biochemical and cellular mechanism of protein kinase CK2 inhibition by deceptive curcumin 160
Fam20C is under the control of sphingolipid signaling in human cell lines 157
Protein Kinase CK2 Inhibitors: Emerging Anticancer Therapeutic Agents? 155
Isoform specific phosphorylation of p53 by protein kinase CK1 152
Autophosphorylation at the regulatory beta subunit reflects the supramolecular organization of protein kinase CK2 149
Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma 149
Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A 147
The selectivity of inhibitors of protein kinase CK2: an update 145
Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitors. 145
Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression 143
A white paper on Phospholipid Hydroperoxide Glutathione Peroxidase (GPx4) forty years later 140
Elucidation of the ribonuclease a aggregation process mediated by 3D domain swapping: A computational approach reveals possible new multimeric structures. 140
Casein kinases as potential therapeutic targets 140
Hydrophobic Derivatives of Glycopeptide Antibiotics as Inhibitors of Protein Kinases 140
Detection of Phospho-Sites Generated by Protein Kinase CK2 in CFTR: Mechanistic Aspects of Thr1471 Phosphorylation 139
A new role for sphingosine: Up-regulation of Fam20C, the genuine casein kinase that phosphorylates secreted proteins 139
Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2 138
ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents 138
Tools to discriminate between targets of CK2 vs PLK2/PLK3 acidophilic kinases. 138
Investigation on PLK2 and PLK3 substrate recognition. 137
Aerobic pyruvate metabolism sensitizes cells to ferroptosis primed by GSH depletion 136
Glutathione peroxidase 4 135
The Golgi ‘casein kinase’ Fam20C is a genuine ‘phosvitin kinase’ and phosphorylates polyserine stretches devoid of the canonical consensus 134
Missing GPx8 activity in ER impacts on lipid composition 133
How Druggable Is Protein Kinase CK2? 132
Scouting Novel Protein Kinase A (PKA) Inhibitors by Using a Consensus Docking-Based Virtual Screening Approach 131
Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases 131
Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems 127
Protein kinase CK2 inhibitors: a patent review 126
Role of carboxylic group pattern on protein surface in the recognition of iron oxide nanoparticles: A key for protein corona formation 125
The landscape of BRAF transcript and protein variants in human cancer 122
Does CK2 start chromatin condensation in mitotic phase? 122
Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery 121
Role of interaction and nucleoside diphosphate kinase b in regulation of the cystic fibrosis transmembrane conductance regulator function by camp-dependent protein kinase a 119
Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2. 119
Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer 118
Kinase CK2 Inhibition: An Update 115
Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2 115
TG2 regulates the heat-shock response by the post-translational modification of HSF1 115
The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131 114
Production and purification of homogenous recombinant human selenoproteins reveals a unique codon skipping event in E. coli and GPX4-specific affinity to bromosulfophthalein 114
DEVELOPMENT OF CK2 INHIBITORS FOR TARGETING DYRK AND PIM KINASES 112
Coumarin as attractive casein kinase 2(CK2) inhibitor scaffold: an integrated approach to elucidate the putative binding motif and explain structure-activity relationship. 112
The development of CK2 inhibitors: From traditional pharmacology to in silico rational drug design 112
The Dark Side of Protein Kinase CK2 Inhibition 111
An Iron Shield to Protect Epigallocatehin-3-Gallate from Degradation: Multifunctional Self-Assembled Iron Oxide Nanocarrier Enhances Protein Kinase CK2 Intracellular Targeting and Inhibition 111
Regulatory subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptide 109
Glutathione Peroxidase-4 109
Novel and old polyamine analogues to target human monoamine oxidases and vascular adhesion protein-1 107
A novel splicing variant encoding putative catalytic alpha subunit of maize protein kinase CK2. 107
Identification of novel protein kinase CK1 delta (CK1 delta) inhibitors through structure-based virtual screening 104
Mechanism of GSH Peroxidases III: GPx4 but not GPx1 binds to polar heads of phospholipids in membranes through a cationic area that also precisely addresses the hydroperoxide groups to the redox centre of the enzyme 104
Subverted signalling by protein kinase CK2 in Delta F508 CFTR expressing cells 104
Inhibition of cell cycle and apoptosis in human cervix carcinoma cell lines induced by rhein, quercetin and plumbagin and in silico designed semi synthetic analogs 103
Development of a yeast-based system to identify new hBRAFV600E functional interactors 103
Glutathione peroxidase 4, pp 223-234. In Selenium. Its Molecular Biology and Role in Human Health. 4th ed. 101
Cardiolipin drives the catalytic activity of GPX4 on membranes: Insights from the R152H mutant 100
The catalytic mechanism of Glutathione Peroxidases 100
Benextramine derivatives as probes to target human monoamine oxidases 98
Biosensor based on aminoaldehyde dehydrogenase-iron nanoparticle complex for aminoaldehydes determination in spirits 97
Highly specific colloidal γ-Fe2O3-DNA hybrids: From bioinspired recognition to large-scale lactoferrin purification 97
Enzyme-iron nanoparticle direct interactions: hybrid formation and application for a coulometric biosensor for aminoaldehydes 96
8-HYDROXYNAPHTHALENE-1,4-DIONES NOVEL JUGLONE DERIVATIVES IN GLIOMA TREATMENT 95
From Monoamine Oxidase Inhibition to Antiproliferative Activity: New Biological Perspectives for Polyamine Analogs 91
Identification of Snps and Indels mutation in ALK kinase domain by 454 massive parallel pyrosequencing 91
Intracellular protein kinase CK2 inhibition by ferulic acid-based trimodal nanodevice 91
Identification of new powerful and selectiveinhibitors of protein kinases CK1δ and CK2 bycomputer aided virtual screening and molecularderivatization of anthraquinone scaffolds 89
Totale 14.835
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.125
article - articoli 44.369
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.054
Totale 97.548
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.264 0 0 0 107 62 80 60 150 206 223 209 167
2021/20221.549 38 208 262 95 72 115 77 139 60 41 143 299
2022/20231.150 229 107 31 152 172 164 4 73 138 10 50 20
2023/2024709 36 110 79 54 75 58 58 51 28 24 74 62
2024/20253.072 99 166 136 118 348 146 247 283 268 88 499 674
2025/20263.591 556 879 1.447 709 0 0 0 0 0 0 0 0
Totale 16.039